{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:02:04Z","timestamp":1779847324148,"version":"3.53.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The State Key Program of the National Natural Science Foundation of China grants","award":["82030064"],"award-info":[{"award-number":["82030064"]}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L246009"],"award-info":[{"award-number":["L246009"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08098-x","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:25:20Z","timestamp":1775928320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the astrocyte-microglia EFEMP1-GALNT10 axis: a spatially programmable therapeutic strategy for hippocampal vulnerability in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Junting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-9797","authenticated-orcid":false,"given":"Peichang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"1","key":"8098_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359.","journal-title":"Signal Transduct Target Ther"},{"key":"8098_CR2","doi-asserted-by":"publisher","first-page":"101451","DOI":"10.1016\/j.arr.2021.101451","volume":"71","author":"R Ullah","year":"2021","unstructured":"Ullah R, Park TJ, Huang X, Kim MO. Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer\u2019s pathology: insights and therapeutic approaches from periphery. Ageing Res Rev. 2021;71:101451.","journal-title":"Ageing Res Rev"},{"key":"8098_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41467-024-44742-0","volume":"15","author":"SS Kim","year":"2024","unstructured":"Kim SS, et al. Leveraging single-cell ATAC-seq and RNA-seq to identify disease-critical fetal and adult brain cell types. Nat Commun. 2024;15:563.","journal-title":"Nat Commun"},{"key":"8098_CR4","doi-asserted-by":"publisher","first-page":"7995","DOI":"10.1038\/s41467-024-52356-9","volume":"15","author":"E Long","year":"2024","unstructured":"Long E, et al. Context-aware single-cell multiomics approach identifies cell-type-specific lung cancer susceptibility genes. Nat Commun. 2024;15:7995.","journal-title":"Nat Commun"},{"key":"8098_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-021-02334-x","volume":"22","author":"Z Mu","year":"2021","unstructured":"Mu Z, et al. The impact of cell type and context-dependent regulatory variants on human immune traits. Genome Biol. 2021;22:122.","journal-title":"Genome Biol"},{"key":"8098_CR6","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1038\/s41467-025-59620-6","volume":"16","author":"Q Pan","year":"2025","unstructured":"Pan Q, et al. scMINER: a mutual information-based framework for clustering and hidden driver inference from single-cell transcriptomics data. Nat Commun. 2025;16:4305.","journal-title":"Nat Commun"},{"key":"8098_CR7","doi-asserted-by":"publisher","first-page":"9005","DOI":"10.1109\/TNNLS.2024.3412753","volume":"36","author":"JC Wang","year":"2025","unstructured":"Wang JC, Chen YJ, Zou Q. GRACE: unveiling gene regulatory networks with causal mechanistic graph neural networks in single-cell RNA-sequencing data. IEEE Trans Neural Netw Learn Syst. 2025;36:9005\u201317.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"key":"8098_CR8","doi-asserted-by":"crossref","unstructured":"Luo X, Qin F, Xiao F, Cai G. BISC: accurate inference of transcriptional bursting kinetics from single-cell transcriptomic data. Brief Bioinform. 2022;23.","DOI":"10.1093\/bib\/bbac464"},{"key":"8098_CR9","doi-asserted-by":"publisher","first-page":"139394","DOI":"10.1016\/j.ijbiomac.2024.139394","volume":"294","author":"S Wang","year":"2025","unstructured":"Wang S, Xi J, Zhang M, Wang J. Identification of potential therapeutic targets for Alzheimer\u2019s disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study. Int J Biol Macromol. 2025;294:139394.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"8098_CR10","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/s41380-024-02840-x","volume":"30","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Guo Y, He Y, You J, Zhang Y, Wang L, et al. Large-scale proteomic analyses of incident Alzheimer\u2019s disease reveal new pathophysiological insights and potential therapeutic targets. Mol Psychiatry. 2025;30(6):2347\u201361. https:\/\/doi.org\/10.1038\/s41380-024-02840-x.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"8098_CR11","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1002\/alz.14142","volume":"20","author":"MR Duggan","year":"2024","unstructured":"Duggan MR, Yang Z, Cui Y, et al. Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration. Alzheimers Dement. 2024;20(9):6486\u2013505.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"8098_CR12","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1038\/s12276-023-01123-9","volume":"55","author":"H Choi","year":"2023","unstructured":"Choi H, Lee EJ, Shin JS, et al. Spatiotemporal characterization of glial cell activation in an Alzheimer\u2019s disease model by spatially resolved transcriptomics. Exp Mol Med. 2023;55(12):2564\u201375.","journal-title":"Exp Mol Med"},{"issue":"2","key":"8098_CR13","doi-asserted-by":"publisher","first-page":"113691","DOI":"10.1016\/j.celrep.2024.113691","volume":"43","author":"M Yu","year":"2024","unstructured":"Yu M, Risacher SL, Nho KT, et al. Spatial transcriptomic patterns underlying amyloid-\u03b2 and tau pathology are associated with cognitive dysfunction in Alzheimer\u2019s disease. Cell Rep. 2024;43(2):113691.","journal-title":"Cell Rep"},{"key":"8098_CR14","doi-asserted-by":"crossref","unstructured":"Chen S, Chang Y, Li L, et al. Spatial transcriptomics of human middle temporal gyrus reveals layer-specific gene expression in early Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2021;17(S3):e050540.","DOI":"10.1002\/alz.050540"},{"issue":"8","key":"8098_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","volume":"9","author":"J Gao","year":"2024","unstructured":"Gao J, Xia Z, Gunasekar S, Jiang C, Karp JM, Joshi N. Precision drug delivery to the central nervous system using engineered nanoparticles. Nat Reviews Mater. 2024;9(8):567\u201388.","journal-title":"Nat Reviews Mater"},{"key":"8098_CR16","doi-asserted-by":"crossref","unstructured":"Ramos Ferrer P, Sakiyama-Elbert S. Affinity-based drug delivery systems for the central nervous system: exploiting molecular interactions for local, precise targeting. J Neural Eng. 2024;21(4).","DOI":"10.1088\/1741-2552\/ad680a"},{"issue":"1","key":"8098_CR17","first-page":"19","volume":"11","author":"SS Zhang","year":"2024","unstructured":"Zhang SS, Li RQ, Chen Z, Wang XY, Dumont AS, Fan X. Immune cells: potential carriers or agents for drug delivery to the central nervous system. Mil Med Res. 2024;11(1):19.","journal-title":"Mil Med Res"},{"key":"8098_CR18","doi-asserted-by":"publisher","first-page":"17605","DOI":"10.1038\/s41598-018-35871-w","volume":"8","author":"AF McRae","year":"2018","unstructured":"McRae AF, et al. Identification of 55,000 Replicated DNA Methylation QTL. Sci Rep. 2018;8:17605.","journal-title":"Sci Rep"},{"key":"8098_CR19","unstructured":"https:\/\/www.eqtlgen.org\/cis-eqtls.html."},{"key":"8098_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet. 2021;53:143\u20136.","journal-title":"Nat Genet"},{"key":"8098_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang C, et al. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci. 2021;24:1302\u201312.","journal-title":"Nat Neurosci"},{"key":"8098_CR22","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53:1712\u201321.","journal-title":"Nat Genet"},{"key":"8098_CR23","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"G Consortium","year":"2020","unstructured":"Consortium G. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330.","journal-title":"Science"},{"key":"8098_CR24","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/s41467-018-04558-1","volume":"9","author":"T Qi","year":"2018","unstructured":"Qi T, et al. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood. Nat Commun. 2018;9:2282.","journal-title":"Nat Commun"},{"key":"8098_CR25","unstructured":"https:\/\/risteys.finngen.fi\/endpoints\/G6_ALZHEIMER."},{"key":"8098_CR26","unstructured":"https:\/\/gwas.mrcieu.ac.uk\/datasets\/ieu-b-5067\/."},{"key":"8098_CR27","unstructured":"https:\/\/www.leelabsg.org\/resources."},{"key":"8098_CR28","unstructured":"https:\/\/www.ebi.ac.uk\/gwas\/studies\/GCST90435837."},{"key":"8098_CR29","unstructured":"https:\/\/yanglab.westlake.edu.cn\/software\/smr."},{"key":"8098_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481\u20137.","journal-title":"Nat Genet"},{"key":"8098_CR31","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u201397.","journal-title":"Nucleic Acids Res"},{"key":"8098_CR32","doi-asserted-by":"crossref","unstructured":"Cotter DJ, Hofgard EF, Novembre J, Szpiech ZA. & Rosenberg, N.A. A rarefaction approach for measuring population differences in rare and common variation. Genetics 224, (2023).","DOI":"10.1093\/genetics\/iyad070"},{"key":"8098_CR33","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41593-024-01669-5","volume":"27","author":"S Narasimhan","year":"2024","unstructured":"Narasimhan S, et al. Apolipoprotein E in Alzheimer\u2019s disease trajectories and the next-generation clinical care pathway. Nat Neurosci. 2024;27:1236\u201352.","journal-title":"Nat Neurosci"},{"key":"8098_CR34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"CC Liu","year":"2022","unstructured":"Liu CC, et al. Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022;25:1020\u201333.","journal-title":"Nat Neurosci"},{"key":"8098_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-024-00988-2","volume":"20","author":"RJ Jackson","year":"2024","unstructured":"Jackson RJ, Hyman BT, Serrano-Pozo A. Multifaceted roles of APOE in Alzheimer disease. Nat Rev Neurol. 2024;20:457\u201374.","journal-title":"Nat Rev Neurol"},{"key":"8098_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, et al. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17:72.","journal-title":"Mol Neurodegener"},{"key":"8098_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","volume":"17","author":"R Fern\u00e1ndez-Calle","year":"2022","unstructured":"Fern\u00e1ndez-Calle R, et al. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol Neurodegener. 2022;17:62.","journal-title":"Mol Neurodegener"},{"key":"8098_CR38","unstructured":"https:\/\/academic.oup.com\/jrsssb\/article\/57\/1\/289\/7035855."},{"key":"8098_CR39","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.2756","volume":"45","author":"HJ Westra","year":"2013","unstructured":"Westra HJ, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45:1238\u201343.","journal-title":"Nat Genet"},{"key":"8098_CR40","first-page":"599","volume":"28","author":"FM Fl\u00f3rio","year":"2023","unstructured":"Fl\u00f3rio FM, Zanin L, Santos J\u00fanior L, Meneghim MC, Ambrosano G. Size effect in observational studies in Public Oral Health: importance, calculation and interpretation. Cien Saude Colet. 2023;28:599\u2013608.","journal-title":"Cien Saude Colet"},{"key":"8098_CR41","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/03610911003650383","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Cohen P, Chen S. How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun Stat - Simul Computation. 2010;39:860\u20134.","journal-title":"Commun Stat - Simul ComputationCommunications Stat - Simul ComputationCommunications Stat - Simul Comput"},{"key":"8098_CR42","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1093\/bioinformatics\/btv340","volume":"31","author":"K Zhang","year":"2015","unstructured":"Zhang K, et al. A note on the false discovery rate of novel peptides in proteogenomics. Bioinformatics. 2015;31:3249\u201353.","journal-title":"Bioinformatics"},{"key":"8098_CR43","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.","journal-title":"PLoS Genet"},{"key":"8098_CR44","doi-asserted-by":"publisher","first-page":"Article17","DOI":"10.2202\/1544-6115.1128","volume":"4","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"8098_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"8098_CR46","unstructured":"http:\/\/gepia2.cancer-pku.cn\/#index."},{"issue":"661","key":"8098_CR47","doi-asserted-by":"publisher","first-page":"eabq0095","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang L, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2022;14(661):eabq0095.","journal-title":"Sci Transl Med"},{"issue":"6760","key":"8098_CR48","doi-asserted-by":"publisher","first-page":"eads3204","DOI":"10.1126\/science.ads3204","volume":"389","author":"ME Pizzo","year":"2025","unstructured":"Pizzo ME, Plowey ED, Khoury N, et al. Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA. Science. 2025;389(6760):eads3204.","journal-title":"Science"},{"issue":"51","key":"8098_CR49","doi-asserted-by":"publisher","first-page":"e2304654","DOI":"10.1002\/adma.202304654","volume":"35","author":"M Sela","year":"2023","unstructured":"Sela M, Poley M, Mora-Raimundo P, et al. Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-synuclein aggregation and improve behavioral symptoms in Parkinson\u2019s disease. Adv Mater. 2023;35(51):e2304654.","journal-title":"Adv Mater"},{"issue":"18","key":"8098_CR50","doi-asserted-by":"publisher","first-page":"e2301361","DOI":"10.1002\/advs.202301361","volume":"10","author":"Y Su","year":"2023","unstructured":"Su Y, Huang Y, Kou Q, et al. Study on the role of an erythrocyte membrane-coated nanotheranostic system in targeted immune regulation of Alzheimer\u2019s disease. Adv Sci (Weinh). 2023;10(18):e2301361.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"8098_CR51","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.7150\/thno.106083","volume":"15","author":"A Casamassa","year":"2025","unstructured":"Casamassa A, Brancaccio P, Campani V, et al. A new nano-encapsulated TSPO ligand reduces neuroinflammation and improves cognitive functions in Alzheimer\u2019s disease model. Theranostics. 2025;15(10):4673\u201392.","journal-title":"Theranostics"},{"issue":"1","key":"8098_CR52","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41467-025-57108-x","volume":"16","author":"N Khoury","year":"2025","unstructured":"Khoury N, Pizzo ME, Discenza CB, et al. Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution. Nat Commun. 2025;16(1):1822.","journal-title":"Nat Commun"},{"key":"8098_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12987-025-00643-y","volume":"22","author":"G Bonvicini","year":"2025","unstructured":"Bonvicini G, et al. The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo. Fluids Barriers CNS. 2025;22:36.","journal-title":"Fluids Barriers CNS"},{"key":"8098_CR54","doi-asserted-by":"publisher","first-page":"212827","DOI":"10.1016\/j.bioadv.2022.212827","volume":"137","author":"F Khonsari","year":"2022","unstructured":"Khonsari F, et al. Transferrin decorated-nanostructured lipid carriers (NLCs) are a promising delivery system for rapamycin in Alzheimer\u2019s disease: an in vivo study. Biomater Adv. 2022;137:212827.","journal-title":"Biomater Adv"},{"issue":"5","key":"8098_CR55","doi-asserted-by":"publisher","first-page":"e2411061","DOI":"10.1002\/adma.202411061","volume":"37","author":"X Wang","year":"2025","unstructured":"Wang X, Chen S, Xia X, et al. Lysosome-targeting protein degradation through endocytosis pathway triggered by polyvalent nano-chimera for AD therapy. Adv Mater. 2025;37(5):e2411061.","journal-title":"Adv Mater"},{"key":"8098_CR56","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.apsb.2022.02.001","volume":"12","author":"X He","year":"2022","unstructured":"He X, et al. Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer\u2019s disease treatment by anti-neuroinflammation and neuroprotection. Acta Pharm Sin B. 2022;12:1987\u201399.","journal-title":"Acta Pharm Sin B"},{"key":"8098_CR57","doi-asserted-by":"publisher","first-page":"1801586","DOI":"10.1002\/advs.201801586","volume":"6","author":"Y Lu","year":"2019","unstructured":"Lu Y, et al. Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia. Adv Sci (Weinh). 2019;6:1801586.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"8098_CR58","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1016\/j.apsb.2024.05.017","volume":"14","author":"X Xia","year":"2024","unstructured":"Xia X, Wei Y, Huang Q, et al. Counteracting Alzheimer\u2019s disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator. Acta Pharm Sin B. 2024;14(12):5464\u201378.","journal-title":"Acta Pharm Sin B"},{"key":"8098_CR59","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jconrel.2023.08.001","volume":"361","author":"LL Israel","year":"2023","unstructured":"Israel LL, Sun T, Braubach O, et al. \u03b2-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer\u2019s disease mouse models. J Control Release. 2023;361:636\u201358.","journal-title":"J Control Release"},{"key":"8098_CR60","doi-asserted-by":"publisher","first-page":"107272","DOI":"10.1016\/j.ejps.2025.107272","volume":"214","author":"M Laabs","year":"2025","unstructured":"Laabs M, Mulac D, Langer K. Targeting the blood-brain barrier with lipoprotein-mimicking nanoparticles loaded with flurbiprofenaxetil and coated with apolipoprotein E3. Eur J Pharm Sci. 2025;214:107272.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"8098_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12987-024-00573-1","volume":"21","author":"L Fritzen","year":"2024","unstructured":"Fritzen L, Wienken K, Wagner L, et al. Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier. Fluids Barriers CNS. 2024;21(1):74.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"8098_CR62","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1080\/10717544.2022.2072543","volume":"29","author":"J Wang","year":"2022","unstructured":"Wang J, Kong L, Guo RB, et al. Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer\u2019s disease. Drug Deliv. 2022;29(1):1648\u201362.","journal-title":"Drug Deliv"},{"issue":"8","key":"8098_CR63","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1021\/jacsau.4c00311","volume":"4","author":"K Sakamoto","year":"2024","unstructured":"Sakamoto K, Iwata S, Jin Z, et al. Cyclic peptides KS-133 and KS-487 multifunctionalized nanoparticles enable efficient brain targeting for treating schizophrenia. JACS Au. 2024;4(8):2811\u20137.","journal-title":"JACS Au"},{"key":"8098_CR64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12974-021-02099-x","volume":"18","author":"AF Batista","year":"2021","unstructured":"Batista AF, et al. Interleukin-1\u03b2 mediates alterations in mitochondrial fusion\/fission proteins and memory impairment induced by amyloid-\u03b2 oligomers. J Neuroinflammation. 2021;18:54.","journal-title":"J Neuroinflammation"},{"key":"8098_CR65","doi-asserted-by":"publisher","first-page":"7064","DOI":"10.1038\/s41467-024-50919-4","volume":"15","author":"B Huang","year":"2024","unstructured":"Huang B, et al. De novo design of miniprotein antagonists of cytokine storm inducers. Nat Commun. 2024;15:7064.","journal-title":"Nat Commun"},{"key":"8098_CR66","doi-asserted-by":"crossref","unstructured":"Platt N et al. Dysregulation of the NLRP3 inflammasome and promotion of disease by IL-1\u03b2 in a murine model of Sandhoff disease. Cells. 2025;14.","DOI":"10.3390\/cells14010035"},{"key":"8098_CR67","doi-asserted-by":"publisher","first-page":"1421455","DOI":"10.3389\/fimmu.2024.1421455","volume":"15","author":"HJ Lee","year":"2024","unstructured":"Lee HJ, et al. Erlotinib regulates short-term memory, tau\/A\u03b2 pathology, and astrogliosis in mouse models of AD. Front Immunol. 2024;15:1421455.","journal-title":"Front Immunol"},{"issue":"1","key":"8098_CR68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/08941939.2020.1811812","volume":"35","author":"X Peng","year":"2022","unstructured":"Peng X, Guo Z, Zhang Y, Sun B, Zhang Q. EFEMP1 in direct inguinal hernia: correlation with TIMP3 and regulation toward elastin homoeostasis as well as fibroblast mobility. J Invest Surg. 2022;35(1):203\u201311.","journal-title":"J Invest Surg"},{"key":"8098_CR69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1476-4598-10-123","volume":"10","author":"Y Hu","year":"2011","unstructured":"Hu Y, et al. EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment. Mol Cancer. 2011;10:123.","journal-title":"Mol Cancer"},{"key":"8098_CR70","first-page":"v59","volume":"16","author":"Y Zhou","year":"2014","unstructured":"Zhou Y. CS-37: Dual functions of EFEMP1 in malignant glioma in respect to regulation of EGFR and NOTCH signaling pathways. Neuro-Oncology. 2014;16:v59\u201359.","journal-title":"Neurooncology"},{"key":"8098_CR71","doi-asserted-by":"crossref","unstructured":"Li W et al. Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy. Elife 12, (2023).","DOI":"10.7554\/eLife.80479"},{"key":"8098_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12974-016-0486-x","volume":"13","author":"S Swaroop","year":"2016","unstructured":"Swaroop S, Sengupta N, Suryawanshi AR, Adlakha YK, Basu A. HSP60 plays a regulatory role in IL-1\u03b2-induced microglial inflammation via TLR4-p38 MAPK axis. J Neuroinflammation. 2016;13:27.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"8098_CR73","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-019-1645-7","volume":"16","author":"F Rivera-Escalera","year":"2019","unstructured":"Rivera-Escalera F, Pinney JJ, Owlett L, et al. IL-1\u03b2-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia. J Neuroinflammation. 2019;16(1):261.","journal-title":"J Neuroinflammation"},{"key":"8098_CR74","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.1021\/jacs.4c17873","volume":"147","author":"WC Powell","year":"2025","unstructured":"Powell WC, et al. Chemical synthesis reveals pathogenic role of N-Glycosylation in microtubule-associated protein Tau. J Am Chem Soc. 2025;147:6995\u20137007.","journal-title":"J Am Chem Soc"},{"key":"8098_CR75","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12974-023-02824-8","volume":"20","author":"X Dong","year":"2023","unstructured":"Dong X, et al. Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-\u03baB signaling pathway. J Neuroinflammation. 2023;20:146.","journal-title":"J Neuroinflammation"},{"key":"8098_CR76","doi-asserted-by":"publisher","first-page":"130347","DOI":"10.1016\/j.ijbiomac.2024.130347","volume":"263","author":"Y Peng","year":"2024","unstructured":"Peng Y, et al. Deficiency of polypeptide N-acetylgalactosamine transferase 9 contributes to a risk for Parkinson\u2019s disease via mitochondrial dysfunctions. Int J Biol Macromol. 2024;263:130347.","journal-title":"Int J Biol Macromol"},{"key":"8098_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13062-024-00524-8","volume":"19","author":"Y Peng","year":"2024","unstructured":"Peng Y, et al. GALNT9 enrichment attenuates MPP+-induced cytotoxicity by ameliorating protein aggregations containing \u03b1-synuclein and mitochondrial dysfunction. Biol Direct. 2024;19:77.","journal-title":"Biol Direct"},{"key":"8098_CR78","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.npep.2017.11.008","volume":"67","author":"I Ramos-Martinez","year":"2018","unstructured":"Ramos-Martinez I, et al. Neuroinflammation induced by amyloid \u03b225\u201335 modifies mucin-type O-glycosylation in the rat\u2019s hippocampus. Neuropeptides. 2018;67:56\u201362.","journal-title":"Neuropeptides"},{"key":"8098_CR79","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1186\/s12967-025-06739-1","volume":"23","author":"S Liu","year":"2025","unstructured":"Liu S, Cho M, Huang YN, Park T, Chaudhuri S, Rosewood TJ, et al. Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer\u2019s disease. J Transl Med. 2025;23:788.","journal-title":"J Transl Med"},{"issue":"1","key":"8098_CR80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/jb\/mvw056","volume":"161","author":"K Akasaka-Manya","year":"2017","unstructured":"Akasaka-Manya K, Kawamura M, Tsumoto H, et al. Excess APP O-glycosylation by GalNAc-T6 decreases A\u03b2 production. J Biochem. 2017;161(1):99\u2013111.","journal-title":"J Biochem"},{"issue":"52","key":"8098_CR81","doi-asserted-by":"publisher","first-page":"21304","DOI":"10.1074\/jbc.M117.814202","volume":"292","author":"F Liu","year":"2017","unstructured":"Liu F, Xu K, Xu Z, et al. The small molecule luteolin inhibits N-acetyl-\u03b1-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein. J Biol Chem. 2017;292(52):21304\u201319.","journal-title":"J Biol Chem"},{"issue":"1","key":"8098_CR82","doi-asserted-by":"publisher","first-page":"7816","DOI":"10.1038\/s41598-023-34787-4","volume":"13","author":"X Tang","year":"2023","unstructured":"Tang X, Tena J, Di Lucente J, et al. Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer\u2019s disease. Sci Rep. 2023;13(1):7816.","journal-title":"Sci Rep"},{"key":"8098_CR83","doi-asserted-by":"publisher","first-page":"101272","DOI":"10.1016\/j.arr.2021.101272","volume":"67","author":"J Zhao","year":"2021","unstructured":"Zhao J, Wu H, Tang XQ. Tau internalization: a complex step in tau propagation. Ageing Res Rev. 2021;67:101272.","journal-title":"Ageing Res Rev"},{"key":"8098_CR84","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12964-024-01928-9","volume":"22","author":"A Raj","year":"2024","unstructured":"Raj A, et al. Dysregulation of protein degradation and alteration of secretome in \u03b1-synuclein-exposed astrocytes: implications for dopaminergic neuronal dysfunction. Cell Commun Signal. 2024;22:574.","journal-title":"Cell Commun Signal"},{"key":"8098_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-024-00846-4","volume":"11","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, et al. Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson\u2019s disease model triggered by \u03b1-synuclein overexpression. NPJ Parkinsons Dis. 2025;11:15.","journal-title":"NPJ Parkinsons Dis"},{"key":"8098_CR86","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.2147\/IJN.S419369","volume":"18","author":"H Singh","year":"2023","unstructured":"Singh H, Desimone MF, Pandya S, et al. Revisiting the green synthesis of nanoparticles: uncovering influences of plant extracts as reducing agents for enhanced synthesis efficiency and its biomedical applications. Int J Nanomed. 2023;18:4727\u201350.","journal-title":"Int J Nanomed"},{"issue":"Pt 1","key":"8098_CR87","doi-asserted-by":"publisher","first-page":"148605","DOI":"10.1016\/j.ijbiomac.2025.148605","volume":"332","author":"X Guo","year":"2025","unstructured":"Guo X, Li F, Wang B, Liu F. Plant-based nanomaterials for sustainable applications in food, medicine, and environmental remediation: a review. Int J Biol Macromol. 2025;332(Pt 1):148605.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"8098_CR88","doi-asserted-by":"publisher","first-page":"e70156","DOI":"10.1111\/1541-4337.70156","volume":"24","author":"GB Bamigbade","year":"2025","unstructured":"Bamigbade GB, Abdin M, Subhash A, et al. Plant polysaccharide-capped nanoparticles: a sustainable approach to modulate gut microbiota and advance functional food applications. Compr Rev Food Sci Food Saf. 2025;24(2):e70156.","journal-title":"Compr Rev Food Sci Food Saf"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08098-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:04:48Z","timestamp":1779843888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08098-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8098"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08098-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Animal Care and Use Committee of Xuanwu Hospital, Capital Medical University and performed in accordance with the guidelines of the Chinese Administration of Laboratory Animals. For publicly available datasets used in this study, no ethics approval and consent to participate was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"699"}}